Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 21, 2012; 18(39): 5581-5588
Published online Oct 21, 2012. doi: 10.3748/wjg.v18.i39.5581
Published online Oct 21, 2012. doi: 10.3748/wjg.v18.i39.5581
Table 3 Protein expression of thioredoxin and thioredoxin-interacting protein in gastric cancers
| Characteristic (n) | TXN overexpressionn (%) | TXNIP underexpressionn (%) |
| Total (328) | 213 (65) | 278 (85) |
| Histologic type | ||
| Diffuse type (228) | 149 (65) | 201 (88) |
| Intestinal type (100) | 64 (64) | 77 (77) |
| P = 0.9 | P = 0.012 | |
| Stage | ||
| Stage I/II (180) | 116 (64) | 142 (79) |
| Stage III/IV (148) | 97 (66) | 136 (92) |
| P = 0.767 | P = 0.009 |
- Citation: Lim JY, Yoon SO, Hong SW, Kim JW, Choi SH, Cho JY. Thioredoxin and thioredoxin-interacting protein as prognostic markers for gastric cancer recurrence. World J Gastroenterol 2012; 18(39): 5581-5588
- URL: https://www.wjgnet.com/1007-9327/full/v18/i39/5581.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i39.5581